TSTickerStarGet alerts

bioAffinity Announces Approximately $4 Million Registered Direct Offering of Common Stock and Concurrent Private Placement Priced At-The-Market

bioAffinity Technologies (NASDAQ: BIAF) entered a definitive agreement with an institutional investor to sell shares of common stock (or pre-funded warrants in lieu thereof) at $6.122 per share ($6.115 per pre-funded warrant) in a registered direct offering priced at-the-market under Nasdaq rules, plus a concurrent private placement of warrants to purchase up to 980,072 shares at $6.122 per share. Gross proceeds are expected to be approximately $4 million before placement agent fees and other expenses, with clos...

Share this story

Key takeaways

  • Registered direct offering of common stock (or pre-funded warrants in lieu) priced at $6.122 per share ($6.115 per pre-funded warrant).

  • Concurrent private placement of warrants for up to 980,072 underlying shares at an exercise price of $6.122 per share.

  • Pre-funded warrants have an exercise price of $0.007 per share; common stock warrants expire five years from stockholder approval.

  • Gross proceeds of approximately $4 million before placement agent fees and offering expenses.

  • Closing expected on or about October 9, 2026, subject to customary closing conditions.

  • WallachBeth Capital, LLC acting as sole placement agent.

  • Use of proceeds: working capital, support expected growing sales for CyPath Lung, and general corporate purposes.

Key metrics

Gross proceeds
approximately $4 million
Common stock purchase price
$6.122 per share
Pre-funded warrant purchase price
$6.115 per warrant
Warrant exercise price
$6.122 per share
Pre-funded warrant exercise price
$0.007 per share
Warrants in private placement (underlying shares)
980,072 shares
Warrant term
5 years from stockholder approval

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow BIAF in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert